“Doc, I didn’t know I was pregnant. Does my baby have fetal alcohol spectrum disorder?”
Green, C., & Cook, J. (2014). “Doc, I didn’t know I was pregnant. Does my baby have fetal alcohol spectrum disorder?”. The International Journal Of Alcohol And Drug Research, 3(1), 117-120. doi:10.7895/ijadr.v3i1.176
How much alcohol is “safe” during pregnancy? This is a question for which there is no conclusive answer. Although no mother wants to intentionally harm her baby, the reality is that consuming alcohol during pregnancy can lead to a variety of complex developmental disabilities, collectively termed Fetal Alcohol Spectrum Disorder (FASD). The precise dosimetry data for the timing and dose of alcohol in pregnancy is unknown, but several features of alcohol metabolism are well characterized and have significant implications for alcohol’s deleterious effects on the developing fetus. There are a number of critical periods in embryonic development, which can be brief or prolonged and that correspond to specific tissues and structures (organ systems). Alcohol at any one of these critical periods can have significant downstream effects on typical fetal development. Alcohol teratogenicity does not produce a single abnormality, but instead can lead to a cluster of birth defects and/or neurodevelopmental abnormalities (i.e., FASD). Each of these cognitive or behavioral problems can vary in its expression, from severe and obvious early in life, to subtle and apparent only years after birth. Based on the variability among women and their fetuses, genetics and environmental influences, it is very unlikely that “absolute risk” for alcohol and pregnancy will ever be established. The age-old question, “How much is too much?”, will also remain unanswered. The best advice: “NO exposure equals NO risk.”
In consideration of publishing this article the authors transfer, assign, or otherwise convey all copyright ownership to the International Journal of Alcohol and Drug Research. By this transfer, the article becomes the property of the International Journal of Alcohol and Drug Research and may not be published elsewhere without written permission from the journal.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. The author(s) will receive no royalty or other monetary compensation for transferring the copyright of the article to the International Journal of Alcohol and Drug Research. IJADR, in turn, grants each author the right to republish the article, without paying royalties to IJADR, in any book of which he or she is the author or editor, subject to the express conditions that (a) the author notify the International Journal of Alcohol and Drug Research in writing of this republication and (b) a credit line attributes the original publication to the International Journal Of Alcohol and Drug Research.
Articles are licenced with a Creative Commons License Deed -- you are free to share articles but must give appropriate attribution, may not use for commercial purposes or distribute modified works. See CC/BY-NC/ND/4.0/.
As the submitting author, and on behalf of all of the manuscript authors I agree with the terms above relating to the copyright transfer of the manuscript to the International Journal of Alcohol and Drug Research.